e1l3n (Cell Signaling Technology Inc)
Structured Review
E1l3n, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1811 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e1l3n/PD-L1+XP+Rabbit+mAb/pm41923627-261-139-167
Average 98 stars, based on 1811 article reviews
Images
Related Articles
Clone Assay:Article Title: Clinical evaluation of a novel-developed clone 3E2 for the detection of PD-L1 expression status in lung adenocarcinoma. Article Snippet: .. Its performance was compared with that of the SP263, Cell Signaling Technology (CST) Immunohistochemistry:Article Title: Clinical evaluation of a novel-developed clone 3E2 for the detection of PD-L1 expression status in lung adenocarcinoma. Article Snippet: .. Its performance was compared with that of the SP263, Cell Signaling Technology (CST) Article Title: First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC Article Snippet: .. The PD-L1 TPS was determined by immunohistochemistry (IHC) by pulmonary pathologists at each center using validated anti–PD-L1 mAbs: Immunohistochemical staining:Article Title: A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer Article Snippet: .. PD-L1 CPS was measured by immunohistochemical quantitative analysis using Dako22C3 pharmDx TM companion diagnostic assay at Foundation Medicine or institutional assay at DFCI using Article Title: A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer. Article Snippet: .. PD-L1 CPS was measured by immunohistochemical quantitative analysis using Dako22C3 pharmDxTM companion diagnostic assay at Foundation Medicine or institutional assay at DFCI using Diagnostic Assay:Article Title: A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer Article Snippet: .. PD-L1 CPS was measured by immunohistochemical quantitative analysis using Dako22C3 pharmDx TM companion diagnostic assay at Foundation Medicine or institutional assay at DFCI using Article Title: A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer. Article Snippet: .. PD-L1 CPS was measured by immunohistochemical quantitative analysis using Dako22C3 pharmDxTM companion diagnostic assay at Foundation Medicine or institutional assay at DFCI using other:Article Title: Frequent NPM1 mutation, monoblastic/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study Article Snippet: PDL1 , E1L3N , Article Title: Epstein-Barr virus orchestrates spatial reorganization and immunomodulation in the classic Hodgkin lymphoma tumor microenvironment. Article Snippet: is a co-founder of Elucidate Bio Inc, has received speaking honorariums from Cell Signaling Technology, and has received research support from Roche and Novartis unrelated to this work. |
